Ryan Kraus

Ryan Kraus joined 1315 Capital in 2020. Previously, he worked as an Analyst at MTS Health Partners, focusing on M&A and financing transactions across the pharmaceutical, biotechnology, and healthcare services subsectors. Prior to MTS, Ryan worked at Pacira BioSciences in Corporate Strategy and Business Development.

Ryan serves as a board observer for 3B Scientific, CHC Solutions, CortiCare, Integration Health, Nu-Tek Bioscience, and SciSafe.

Ryan received a BS in Finance, summa cum laude, from Rutgers University.